• Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Stock Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Education Center
    • Browse Hedge Funds
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up
Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.

Posts Tagged ‘Sanofi Aventis (SNY)’

Ken Griffin

Sanofi-Aventis Purchases $42.4 Million Worth of Regeneron Pharmaceuticals Inc (REGN)’s Stock

On Jan. 29th, Sanofi-Aventis, a European pharmaceutical group and Large Shareholder at Regeneron Pharmaceuticals Inc (NASDAQ:REGN), filed a Form 4 report...

Keep Reading →

January 29 - Insider Trading, News - Comments

Abrams Capital Management

Abrams Capital Management Trims the Stake in Engility Holdings Inc (EGL)

Abrams Capital Management, led by David Abrams significantly trimmed its stake in Engility Holdings Inc (NYSE:EGL). According to a newly amended filing...

Keep Reading →

December 30 - Hedge Funds, News - Comments

AstraZeneca plc (ADR) (NYSE:AZN)

Everything You Need to Know About the Upcoming Flu Season

To me, flu season is a lot like Christmas; there’s a defined time period when we expect it to occur, yet it seems to appear earlier and earlier...

Keep Reading →

September 23 - News - Comments

ISIS Pharmaceuticals, Inc.

Four Reasons to Buy This Biotechnology Stock

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), a developer and marketer of RNA-based novel drugs to treat a variety of diseases, has been one of the best...

Keep Reading →

September 20 - News - Comments

Unilife Corp (NASDAQ:UNIS)

Sanofi SA (ADR) (SNY), Biodel Inc (BIOD): Would It Be Foolish to Trust Unilife Corp (UNIS)?

Shares of drug delivery systems manufacturer Unilife Corp (NASDAQ:UNIS) recently rallied after it announced a long-term contract to sell prefilled syringes...

Keep Reading →

September 18 - News - Comments

Sanofi SA (ADR) (NYSE:SNY)

Sanofi SA (ADR) (SNY), Roche Holding Ltd. (ADR) (RHHBY), GlaxoSmithKline plc (ADR) (GSK): Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?

There is perhaps nothing scarier than a cancer diagnosis. A study in 2010 conducted by Cancer Research UK demonstrated this to the “T,” when...

Keep Reading →

September 17 - News - Comments

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Regeneron Pharmaceuticals Inc (REGN): Should You Follow in Sanofi SA (ADR) (SNY)’s Footsteps and Invest in This Booming Biotech?

More than anything, biotech companies need investors who are true believers in their products. In a sector more governed by future prospects than past...

Keep Reading →

September 17 - News - Comments

Sanofi SA (ADR) (NYSE:SNY)

Sanofi SA (ADR) (SNY), Regeneron Pharmaceuticals Inc (REGN): Getting Closer

When you have $5.5 billion in your wallet, it’s understandable if there’s a hankering to spend some of it. French drugmaker Sanofi SA (ADR...

Keep Reading →

September 17 - News - Comments

Viropharma Inc (NASDAQ:VPHM)

Sanofi SA (ADR) (SNY), Shire PLC (ADR) (SHPG): Making Sense of the Drama About Viropharma Inc (VPHM)

In the world of small biotech companies, investors are always fishing for the next small fish to be gobbled up by a bigger one since the industry is well...

Keep Reading →

September 16 - News - Comments

Sanofi SA (ADR) (NYSE:SNY)

Regeneron Pharmaceuticals Inc (REGN), Viropharma Inc (VPHM): Sanofi SA (ADR) (SNY)’s Interest Sparks Biotech Stocks in a Huge Week for Investors

Looking for the best-performing sector in this year’s big market rally? It may just be the biotech sector, which has erupted with astronomical gains...

Keep Reading →

September 16 - News - Comments

Keryx Biopharmaceuticals (NASDAQ:KERX)

Amgen, Inc. (AMGN), Impax Laboratories Inc (IPXL): Keryx Biopharmaceuticals (KERX)’s Stifel Conference Presentation

Think of The Motley Fool as kind of your TiVo for investment conferences. We’ll help you skip to the good parts and zip past all the rest. There...

Keep Reading →

September 15 - News - Comments

GameStop Corp. (NYSE:GME)

GameStop Corp. (GME), Safeway Inc. (SWY), Regeneron Pharmaceuticals Inc (REGN): Friday’s Three Best Stocks

Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case...

Keep Reading →

September 14 - News - Comments

Apple Inc. (NASDAQ:AAPL)

Apple Inc. (AAPL), NIKE, Inc. (NKE): The Mobile Future of Diabetes Treatments

In my opinion, the Nike+ FuelBand released by Apple Inc. (NASDAQ:AAPL) and NIKE, Inc. (NYSE:NKE) last year was a seminal product in health care tech...

Keep Reading →

September 11 - News - Comments

Unilife Corp (NASDAQ:UNIS)

Sanofi SA (ADR) (SNY), Biodel Inc (BIOD): When Will Unilife Corp (UNIS) Earnings Go Positive?

Unilife Corp (NASDAQ:UNIS) will release its quarterly report on Tuesday, but investors already have reason to believe that the company won’t make...

Keep Reading →

September 9 - News - Comments

Peregrine Pharmaceuticals (NASDAQ:PPHM)

Sanofi SA (ADR) (SNY), Bristol Myers Squibb Co. (BMY): Why Peregrine Pharmaceuticals (PPHM) Earnings Won’t Show Profits

Peregrine Pharmaceuticals (NASDAQ:PPHM) will release its latest quarterly report on Monday, and investors are under no illusions that the company will...

Keep Reading →

September 5 - News - Comments

Novartis AG (ADR) (NYSE:NVS)

Biogen Idec Inc. (BIIB), Incyte Corporation (INCY): Should Novartis AG (ADR) (NVS) Shareholders Be Worried About This?

As an investor in the health care sector, it can sometimes feel like everything — and everyone — is out to get you. The ongoing threat of...

Keep Reading →

August 30 - News - Comments

Allergan, Inc. (NYSE:AGN)

Allergan, Inc. (AGN), Sanofi SA (ADR) (SNY): New FDA Guidelines Hit This Company Hard

Allergan, Inc. (NYSE:AGN), the diversified health care giant best known for Botox, boasts an impressive portfolio of products. From the Lap-band surgical...

Keep Reading →

August 30 - News - Comments

Zoetis Inc (NYSE:ZTS)

Pfizer Inc. (PFE), Zoetis Inc (ZTS), Merck & Co., Inc. (MRK), Sanofi SA (ADR) (SNY): 5 Reasons to Invest in Animal Health

In an attempt to further simplify its business and unlock shareholder value, Pfizer Inc. (NYSE:PFE) has been busy divesting itself of non-core assets...

Keep Reading →

August 29 - News - Comments

Eli Lilly & Co. (NYSE:LLY)

Eli Lilly & Co. (LLY), Merck & Co., Inc. (MRK), Sanofi SA (ADR) (SNY): Positive News for This Troubled Pharma Player

Eli Lilly & Co. (NYSE:LLY) recently rose nearly 3% following positive phase 3 results for cancer drug necitumumab. The company had previously halted...

Keep Reading →

August 27 - News - Comments

Peregrine Pharmaceuticals (NASDAQ:PPHM)

Peregrine Pharmaceuticals (PPHM), Sanofi SA (ADR) (SNY): Is This Experimental Lung Cancer Drug Back on Track?

Peregrine Pharmaceuticals (NASDAQ:PPHM), a developmental stage biotech focusing on oncology treatments, recently announced that its lead drug candidate...

Keep Reading →

August 23 - News - Comments

Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (PFE), Regeneron Pharmaceuticals Inc (REGN): Are These Drugs the Future of High-Cholesterol Treatment?

Research into next-generation cholesterol drugs is picking up. Source: Wikimedia Commons. Once upon a time in a regulatory environment far, far away,...

Keep Reading →

August 21 - News - Comments

Biogen Idec Inc (NASDAQ:BIIB)

Biogen Idec Inc. (BIIB), Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Novartis AG (ADR) (NVS): Companies Leading the Fight Against Multiple Sclerosis

It’s a disease that doesn’t often find itself in the spotlight, but multiple sclerosis is quickly becoming an ailment that drugmakers are...

Keep Reading →

August 19 - News - Comments

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (ADR) (SNY): This Pharma Stock Is Ready to Reach New Heights

Earlier this year, in May, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) was soaring on news of FDA approval of the Eylea injection. The market valued...

Keep Reading →

August 12 - News - Comments

Dendreon Corporation (NASDAQ:DNDN)

Dendreon Corporation (DNDN), Merrimack Pharmaceuticals Inc (MACK), Novavax, Inc. (NVAX): Three Horrendous Health-Care Stocks This Week

August might be hot for most of the country, but the first full week of the month wasn’t so hot for some stocks. Here are some of the most horrendous...

Keep Reading →

August 12 - News - Comments

GlaxoSmithKline plc (ADR) (NYSE:GSK)

GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): The 10 Most Common Reasons People Visit Their Doctor

With the full implementation of the individual portion of the Patient Protection and Affordable Care Act less than five months away, physicians and doctor...

Keep Reading →

August 12 - News - Comments

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (ADR) (SNY): Is This Biotech Slowing?

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) closed Tuesday down over 6% following a second quarter report that missed estimates. A particular cause for...

Keep Reading →

August 9 - News - Comments

Sanofi SA (ADR) (NYSE:SNY)

Sanofi SA (ADR) (SNY), GlaxoSmithKline plc (ADR) (GSK): This Company Is Tackling Multiple Sclerosis Head On

Note: This article has been amended to better reflect Lemtrada’s market position. Currently existing immunomodulatory drugs that treat Multiple...

Keep Reading →

August 8 - News - Comments

Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)

Aegerion Pharmaceuticals, Inc. (AEGR), ISIS Pharmaceuticals, Inc. (ISIS), Sanofi SA (ADR) (SNY): This Is One Incredible CEO

The Motley Fool’s readers have spoken, and I have heeded their cries. After months of pointing out CEO gaffes and faux pas, I’ve decided...

Keep Reading →

August 7 - News - Comments

ISIS Pharmaceuticals, Inc.

Questcor Pharmaceuticals Inc (QCOR), ISIS Pharmaceuticals, Inc. (ISIS): Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape

As human beings it can sometimes be difficult for us to see the good in a bad situation. In the biotech sector, where developing a drug can cost hundreds...

Keep Reading →

August 7 - News - Comments

Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (PFE), Amgen, Inc. (AMGN): The Best-Selling Medications of 2013 (So Far)

Believe it or not, 2013 is getting close to being two-thirds of the way over. Many pharmaceutical firms have enjoyed great stock returns and nice profits...

Keep Reading →

August 6 - News - Comments

Pfizer Inc. (NYSE:PFE)

Pfizer Inc. (PFE), Merck & Co., Inc. (MRK): Will Zoetis Earnings Deliver on Post-Spinoff Growth?

Zoetis will release its quarterly report on Tuesday, and investors will get their first look at the company as a completely independent business entity...

Keep Reading →

August 5 - News - Comments

Array Biopharma Inc (NASDAQ:ARRY)

Array Biopharma Inc (ARRY), Sanofi SA (ADR) (SNY), Regeneron Pharmaceuticals Inc (REGN): Three Ways Your Kids Can Be Harmed by Smog

Around four in 10 Americans live in places where smog can impact their health. Children and teens are especially vulnerable to higher levels of ozone...

Keep Reading →

August 5 - News - Comments

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

Will Regeneron Pharmaceuticals Inc (REGN) Earnings Grow Fast Enough for Investors?

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) will release its quarterly report on Tuesday, and the company’s stock has been on an absolute tear over...

Keep Reading →

August 2 - News - Comments

Keryx Biopharmaceuticals (NASDAQ:KERX)

Three Things You Need to Know From Keryx Biopharmaceuticals (KERX)’s Q2 Earnings

Keryx Biopharmaceuticals (NASDAQ:KERX) announced its second-quarter results before the market opened on Thursday. Shares fell slightly as investors reacted...

Keep Reading →

August 1 - News - Comments

Novo Nordisk A/S (ADR) (NYSE:NVO)

Novo Nordisk A/S (ADR) (NVO): Three Shocking Numbers on Diabetes’ Grim Future

Diabetes is one of the world’s most dangerous and fastest-growing afflictions. According to the International Diabetes Federation, 366 million people...

Keep Reading →

August 1 - News - Comments

Biogen Idec Inc (NASDAQ:BIIB)

Biogen Idec Inc (BIIB), Pfizer Inc. (PFE): Out With the Old, In With the New in Treating MS

Hidden beneath all the numbers and metrics in Biogen Idec Inc (NASDAQ:BIIB)‘s recent earnings report is a key confirmation of a shifting market...

Keep Reading →

August 1 - News - Comments

Sanofi SA (ADR) (NYSE:SNY)

Sanofi SA (ADR) (SNY), Vanda Pharmaceuticals Inc. (VNDA), Merck & Co., Inc. (MRK) – Sleep War Z: A Written History of the Insomniac War

It’s estimated that 30% to 40% of adults in the world experience some degree of insomnia every year. Most of these cases aren’t chronic and do not...

Keep Reading →

August 1 - News - Comments

Questcor Pharmaceuticals Inc (NASDAQ:QCOR)

Things You Need to Know From Questcor Pharmaceuticals Inc (QCOR)’s Killer Q2 Earnings

Three months ago after Questcor Pharmaceuticals Inc (NASDAQ:QCOR) announced its first-quarter financial results, I asked if those results were as bad...

Keep Reading →

July 31 - News - Comments

The Procter & Gamble Company (NYSE:PG)

The Procter & Gamble Company (PG), Merck & Co., Inc. (MRK): The Six Biggest Risk Factors for Insomnia

We often take sleep, the number of hours we get to sleep, or the quality of sleep we get, for granted. However, that may not be such a wise idea, as insomnia...

Keep Reading →

July 29 - News - Comments

Celgene Corporation (NASDAQ:CELG)

Celgene Corporation (CELG): Has Multiple Myeloma Met its Match?

Multiple myeloma is a cancer of plasma cells, a type of white blood cell present in bone marrow. This cancer can lead to abnormally high calcium levels...

Keep Reading →

July 26 - News - Comments

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Four Potential Suitors for Onyx Pharmaceuticals, Inc. (ONXX)

The “people familiar with the matter” are out in full force spouting off about who’s bidding for Onyx Pharmaceuticals, Inc. (NASDAQ...

Keep Reading →

July 19 - News - Comments

Merck & Co., Inc. (NYSE:MRK)

Merck & Co., Inc. (MRK)’s Late-Stage Breakdown

The Food and Drug Administration cancelled an advisory meeting planned for Merck & Co., Inc. (NYSE:MRK)’s post-surgery drug sugammadex. It’s...

Keep Reading →

July 19 - News - Comments

Sanofi SA (ADR) (NYSE:SNY)

The Future of Sanofi SA (ADR) (SNY)’s Insulin Empire

Sanofi SA (ADR) (NYSE:SNY) appeared at the American Diabetes Association meeting last month, touting data for the new insulin U300 and a combo therapy...

Keep Reading →

July 18 - News - Comments

Eli Lilly & Co. (NYSE:LLY)

Could This Safe Play Help Eli Lilly & Co. (LLY)?

Note: This version has been amended to better reflect Victoza’s dosage recommendations. At the American Diabetes Association meeting last month,...

Keep Reading →

July 12 - News - Comments

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

Exploding Pipeline Makes BioMarin Pharmaceutical Inc. (BMRN) Attractive Takeover Target

The Orphan Drug pipeline of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) has been growing so rapidly that the company has been the object of many takeover...

Keep Reading →

July 11 - News - Comments

Eli Lilly & Co. (NYSE:LLY)

Could This Safe Play Help Eli Lilly & Co. (LLY)?

At the American Diabetes Association meeting last month, Eli Lilly & Co. (NYSE:LLY) presented promising data for the GLP-1 agonist dulaglutide. GLP...

Keep Reading →

July 10 - News - Comments

The Boeing Company (NYSE:BA)

The Boeing Company (BA), Lockheed Martin Corporation (LMT) – Pentagon Watch: Where Did Your Tax Dollars Go This Week?

The U.S. military has a reputation as a somewhat secretive organization. But in one respect at least, the Pentagon ranks among our most transparent government...

Keep Reading →

July 8 - News - Comments

NPS Pharmaceuticals, Inc. (NASDAQ:NPSP)

Aegerion Pharmaceuticals, Inc. (AEGR), NPS Pharmaceuticals, Inc. (NPSP): Three of the World’s Rarest Diseases (and the Uncommon Profits They Bring)

Imagine finding out that you have a disease that only a handful of people around the world have. Kirstie and Catherine Fields don’t have to imagine...

Keep Reading →

July 5 - News - Comments

Dendreon Corporation (NASDAQ:DNDN)

Dendreon Corporation (DNDN), Johnson & Johnson (JNJ), Medivation Inc (MDVN): The Most Expensive Drugs in the World

The prescription-drug market currently generates a whopping $950 billion in annual sales, and that figure is likely to grow to $1.2 trillion by 2016....

Keep Reading →

July 3 - News - Comments

AstraZeneca plc (ADR) (NYSE:AZN)

AstraZeneca plc (ADR) (AZN), Sanofi SA (ADR) (SNY): Don’t Ignore These European Healthcare Stocks

Healthcare stocks have rallied over the past couple years, and for good reason. Not only is the global economy gaining traction, but the demographic trends...

Keep Reading →

June 28 - News - Comments

« Older Entries
Insider Monkey HF Resource Center
  • Subscribe to Hedge Fund Alpha
  • How to Beat the Market by 20 Percentage Points
  • Why Track Hedge Funds?
  • Download a Free Edition!
  • Why You Should DUMP Your Hedge Funds
Top Hedge Funds
Warren Buffett

Warren Buffett

Berkshire Hathaway

$202,411,166,000

David Einhorn

David Einhorn

Greenlight Capital

$922,283,000

George Soros

George Soros

Soros Fund Management

$4,481,502,000

Jim Simons

Jim Simons

Renaissance Technologies

$115,840,763,000

Leon Cooperman

Leon Cooperman

Omega Advisors

$873,897,000

Carl Icahn

Carl Icahn

Icahn Capital LP

$19,724,532,000

Steve Cohen

Steve Cohen

Point72 Asset Management

$15,331,618,000

John Paulson

John Paulson

Paulson & Co

$3,129,243,000

David Tepper

David Tepper

Appaloosa Management LP

$5,758,450,000

Paul Tudor Jones

Paul Tudor Jones

Tudor Investment Corp

$2,017,669,000

Insider Monkey Small Cap Strategy
Most Read Posts
Dump Your Hedge Funds and Buy This Stock
World’s Most Expensive Desserts
The 10 Best Selling Products Online
The 10 Best Selling Items on Etsy
The 12 Most Profitable Small Businesses
The 10 Best-Selling Video Games of All Time
Lists

20 Most Valuable Companies In The World in February 2021

Top 15 Pharmaceutical Companies With Highest R&D Spending

Top 5 Financial Centers/Cities of The World

Top 15 Financial Centers/Cities of The World

15 Most Valuable Cloud Computing Companies

5 Most Valuable Cloud Computing Companies

15 Fastest-Growing Fintech Companies

5 Fastest-Growing Fintech Companies

15 Biggest Companies That Accept Bitcoin

15 Youngest Tech Billionaires

Top 15 Serial Entrepreneurs In The World

15 Most Powerful and Influential Companies

12 Most Influential Entrepreneurs in America

15 Richest People in Central and South America

10 Emerging Energy Technologies You Can Invest In Today

15 Richest People In Canada

15 Biggest Water Companies in the World

15 Biggest Acquisitions Of All Time

15 Fastest Growing Dividend Stocks

15 Biggest VC Companies in the World

5 Biggest VC Companies in the World

15 Biggest Trucking Companies in the World

15 Biggest Tech Hardware Companies in the World

5 Biggest Tech Hardware Companies in the World

15 Biggest Wine Companies in the World

25 Highest Earning Billionaires in 2020

15 Fastest-Growing Software Companies

15 Biggest Yogurt Companies in the World

Easily Digestible and Delicious Recipes For Elderly

5 Fastest-Growing Software Companies

5 Fastest-Growing Engineering Fields

15 Biggest Lithium Mining Companies in the World

15 Fastest-Growing Engineering Fields

15 Biggest Companies That Went Bankrupt

Top 10 Most Deadliest and Dangerous Snakes In the World

20 Most Deadliest and Dangerous Snakes In the World

10 Easiest Occupational Therapy Schools To Get Into

Top 5 Easiest Occupational Therapy Schools To Get Into

15 Biggest Money Transfer Companies in the World

5 Biggest Wine Companies in the World

15 Fastest Growing Franchises

15 Biggest Bribery Cases in Business History

25 Fastest Growing Mid size Cities in the US

10 Biggest Gay Events in the United States

10 Best Online Brokers for Non-US Residents

5 Biggest Yogurt Companies in the World

15 Most Successful Products From Shark Tank

10 Biggest Companies Competing With Netflix

15 Biggest 3D Companies in the World

20 Fastest Growing Tech Cities in the World

Read Me
  • 10 Strategies Hedge Funds Use To Make Huge Returns
  • 5 Best Poker Books For Beginners
  • 15 Highest Grossing Movies Opening Weekend
  • Top 10 Genetically Modified Food In the US
  • 10 Best Places To Visit In Canada
  • Best Summer Jobs For Teachers
  • Top 10 Fast Food Franchises To Buy
  • 10 Youngest Hedge Fund Billionaires
  • Top 10 One Hit Wonders of The 90s
  • Fastest Growing Cities In America
  • 10 Places To Visit Before You Die
  • Best Places To Visit In The USA
  • 10 Most Powerful Countries In The World
  • 25 Best Star Wars Video Games Of All Time
  • Top 10 Richest Cities In The World
  • 10 Most Expensive Homes In The World
  • Best Summer Jobs For College Students
  • 20 Best TED Talks Of All Time
  • 8 Most Corrupt Countries In The World
  • 10 Most Expensive Cities In The World
  • 6 Longest Prison Sentences Ever Given
  • 10 Most Profitable Franchises in 2014
  • 10 Best Warren Buffett Quotes On Life, Investing
  • 10 Most Profitable Small Businesses
  • Top 10 Paid Apps For iPhone 5
Blogroll
  • Acting Man
  • Crackerjack Finance
  • Dividend Monk
  • Farmer's TSX Dividend Listing
  • Pension Pulse
Home Hedge Funds Markets Blog Site Map
Authors About Us Contact Us Privacy Policy Terms of Use CCPA - Do Not Sell My Information
All text and design is copyright ©2021 Koala Guide LLC. All rights reserved.